Gwendolyn Knowlton Binder-Scholl Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gwendolyn Knowlton Binder-Scholl.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gwendolyn Knowlton Binder-Scholl. Gwendolyn Knowlton Binder-Scholl is a Chief Technology Officer in Adaptimmune Therapeutics PLC ($ADAP) and a EVP, Adaptimmune LLC in Adaptimmune Therapeutics PLC ($ADAP).
Address: 1903 CARPENTER STREET PHILADELPHIA 19146 PA
Companies in which Gwendolyn Knowlton Binder-Scholl is an Insider
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Gwendolyn Knowlton Binder-Scholl: Chief Technology Officer, EVP, Adaptimmune LLC
Holdings: 2,487 shares
Current Value: $11,266
Latest Transaction: Jan 16 2019
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gwendolyn Knowlton Binder-Scholl
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16 2019 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | Chief Technology Of ... | Sell | S | 5.37 | 1,514 | 8,129 | 2,487 | 4 K to 2.5 K (-37.84 %) |
| Oct 02 2018 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | Chief Technology Of ... | Sell | S | 13.79 | 25,000 | 344,750 | 0 | 25 K to 0 (-100.00 %) |
| Aug 31 2018 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | Chief Technology Of ... | Sell | S | 10.25 | 25,000 | 256,250 | 0 | 25 K to 0 (-100.00 %) |
| Jan 17 2018 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | Chief Technology Of ... | Option Exercise | A | 0.00 | 96,036 | 134 | 96,036 | |
| Jan 17 2018 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | Chief Technology Of ... | Option Exercise | A | 1.30 | 429,984 | 558,979 | 429,984 | |
| Jan 18 2017 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | Chief Technology Of ... | Option Exercise | A | 0.72 | 2,072,976 | 1,492,543 | 2,072,976 | |
| Jan 20 2016 | ADAP | Adaptimmune Therap ... | Binder-Scholl Gwendolyn Knowlt ... | EVP, Adaptimmune LL ... | Option Exercise | A | 1.27 | 704,961 | 896,499 | 704,961 |
View all Gwendolyn Knowlton Binder-Scholl insider transactions.